IRIS
IACCARINO, ANTONINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.010
EU - Europa 576
AS - Asia 262
AF - Africa 21
SA - Sud America 2
Totale 1.871
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.004
IT - Italia 345
SG - Singapore 179
CN - Cina 53
DE - Germania 51
NL - Olanda 38
GB - Regno Unito 24
IE - Irlanda 21
CI - Costa d'Avorio 19
SE - Svezia 19
ES - Italia 18
FI - Finlandia 17
GR - Grecia 15
IN - India 15
UA - Ucraina 12
FR - Francia 10
CA - Canada 6
VN - Vietnam 5
PK - Pakistan 4
BE - Belgio 3
JP - Giappone 3
BR - Brasile 2
BD - Bangladesh 1
EG - Egitto 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
MD - Moldavia 1
RO - Romania 1
SC - Seychelles 1
Totale 1.871
Salva come PNG Salva come JPEG
Città #
Chandler 218
Singapore 149
Ashburn 91
Naples 90
Millbury 53
Napoli 51
Lawrence 41
Santa Clara 40
Amsterdam 37
Des Moines 26
Wilmington 22
Beijing 21
Boston 18
Valencia 15
Heraklion 14
Munich 11
Fairfield 10
Nanjing 10
Milan 9
Princeton 8
Rome 8
Helsinki 7
Salerno 7
Bologna 6
Dublin 6
Grosseto 6
Woodbridge 6
Krefeld 5
Ottawa 5
Pune 5
Caserta 4
Dong Ket 4
Houston 4
Karachi 4
Kronberg 4
Redwood City 4
Washington 4
Bad Durrheim 3
Boardman 3
Lappeenranta 3
Messina 3
Montalto di Castro 3
Nanchang 3
Pagani 3
Portici 3
Ronco all'Adige 3
Salt Lake City 3
Seattle 3
Avellino 2
Brindisi 2
Cagliari 2
Cava Manara 2
Dallas 2
Ferrara 2
Formia 2
Frankfurt am Main 2
Jacksonville 2
Los Angeles 2
Monza 2
New York 2
Pozzuoli 2
Reggio Calabria 2
Scafati 2
Shanghai 2
Somma Vesuviana 2
São Paulo 2
Alatri 1
Angri 1
Ardabil 1
Aversa 1
Bari 1
Brussels 1
Casoria 1
Castelbuono 1
Cava De' Tirreni 1
Cerro Maggiore 1
Changchun 1
Chennai 1
Chisinau 1
Chittagong 1
Collegno 1
Crispano 1
Dongguan 1
Dresden 1
Eboli 1
Edinburgh 1
Espoo 1
Felitto 1
Fiuggi 1
Florence 1
Forio 1
Fuzhou 1
Galati 1
Genoa 1
Genova 1
Greve in Chianti 1
Grezzana 1
Guangzhou 1
Gurgaon 1
Hanoi 1
Totale 1.126
Salva come PNG Salva come JPEG
Nome #
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors 92
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation 76
Analysis of human primary fibroblast spheroids 71
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts 60
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 58
Beta-Catenin Regulates Deiodinase Levels and Thyroid Hormone Signaling in Colon Cancer Cells 51
UbcH10 expression in human lymphomas. 49
Metabolites profiling of melanoma interstitial fluids reveals uridine diphosphate as potent immune modulator capable of limiting tumor growth 45
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 45
Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation 44
BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients 43
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 42
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 42
The continuing role of breast fine-needle aspiration biopsy after the introduction of the IAC Yokohama System For Reporting Breast Fine Needle Aspiration Biopsy Cytopathology 41
The Reproducibility of the Immunohistochemical PD-L1 Testing in Non-Small-Cell Lung Cancer: A Multicentric Italian Experience 39
PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation 39
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 38
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 37
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 36
Is the Idylla EGFR Mutation Assay feasible on archival stained cytological smears? A pilot study 35
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 35
A Roadmap for a Comprehensive Diagnostic Approach to Fine Needle Cytology of Lymph Node Metastases 32
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 32
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 32
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 31
UbcH10 expression on thyroid fine-needle aspirates. 31
Methods for actionable gene fusion detection in lung cancer: now and in the future 31
Cytology in the time of coronavirus disease (covid-19): An Italian perspective 30
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 30
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 30
Cytopathology practice during the COVID-19 postlockdown: An Italian experience 30
Predictive molecular pathology in the time of COVID-19 29
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer 28
Cytology versus histology for programmed death-ligand 1 expression evaluation in the landscape of non-small cell lung cancer patients selection for immunotherapy 27
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 27
BRAF: A Two-Faced Janus 26
PD-L1 and beyond: Immuno-oncology in cytopathology 26
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 25
Foamy gland pancreatic ductal adenocarcinoma diagnosed on EUS-FNA: A histochemical, immunohistochemical, and molecular report 25
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 25
Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload 24
Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein 23
PD-L1 expression on routine samples of non-small cell lung cancer: Results and critical issues from a 1-year experience of a centralised laboratory 23
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 23
Tissue Microarray from Cell Block Material (cbTMA)—An Additional Shot for Cytology in the Predictive Pathology Era: The PD-L1 Experience 22
Tumor mutational burden on cytological samples: A pilot study 21
A novel approach to classification and reporting of lymph node fine-needle cytology: Application of the proposed sydney system 21
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 20
Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries 20
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 19
COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study 19
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 19
A narrative review of predictive immuno-histo/cyto chemistry in lung cancer: focus on gene fusions and PD-L1 expression 18
Molecular predictive testing in precision oncology: The Italian experience 18
Juggling the COVID-19 pandemic: A cytopathology point of view 18
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 17
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 17
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 16
Reference standards for gene fusion molecular assays on cytological samples: an international validation study 13
A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers 12
NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through FAS/CD95 Inhibition 11
Predictive molecular pathology in the time of coronavirus disease (COVID-19) in Europe 9
Pathology in non-small cell lung cancer: evolving scenario 9
Totale 1.977
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 2 0 0 15 0 9 21 2
2020/2021184 2 0 10 2 4 44 8 28 33 26 20 7
2021/2022359 10 10 8 14 6 1 9 34 24 43 94 106
2022/2023554 54 23 26 32 82 71 2 50 93 47 61 13
2023/2024414 31 56 40 23 15 32 9 79 17 14 53 45
2024/2025289 103 104 7 24 51 0 0 0 0 0 0 0
Totale 1.977